Galileo Genomics

company

About

Galileo genomics is a Montreal-based private genetics company that conducts research in Quebecers of French descent using cutting-edge.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$8.96M
Industries
Genetics,Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1999
Number Of Employee
51 - 100
Operating Status
Active

Galileo genomics is a Montreal-based private genetics company that conducts research in Quebecers of French descent using cutting-edge technologies, to identify genes that cause disease, thus providing validated targets for creation of innovative and more effective therapies and diagnostics. The Quebec founder population is the largest such population worldwide, which facilitates rapid patient recruiting. Because of the relatively late founding of the population in the 17th century, the relatively small number of founders, rapid early population growth, minimal intermarriage with other groups, and loss of some family lines while others expanded dramatically, the population is among the most homogeneous and has among the highest genetic sharing of all major founder populations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$25.46M
Galileo Genomics has raised a total of $25.46M in funding over 2 rounds. Their latest funding was raised on Jan 8, 2004 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 8, 2004 Series Unknown $8.96M 1 Detail
Oct 10, 2001 Series Unknown $16.50M 2 Investissement Desjardins Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Galileo Genomics is funded by 3 investors. Investissement Desjardins and Biofund are the most recent investors.
Investor Name Lead Investor Funding Round
Investissement Desjardins Yes Series Unknown
Biofund Series Unknown
Biotech Turnaround Fund (BTF) Series Unknown